Paul Walker

Paul Walker is a General Partner at New Enterprise Associates (NEA) in Menlo Park, California, specializing in investments in the pharmaceuticals, biotech, health IT, and health & hospital services sectors. He has a successful track record of post-IPO equity investments in companies like Allakos, Regulus Therapeutics, and Geron, as well as leading Series B investments in TRACON Pharmaceuticals. Walker's role as a General Partner at NEA involves investing in high-growth companies at various stages, with notable successes in post-IPO equity investments and Series B funding rounds for innovative pharmaceutical and biotech companies in the San Francisco Bay Area.